Waters (WAT) is higher today after Evercore ISI upgraded the stock to Outperform from In Line and set a new $350 price target, signaling a more constructive view on execution and near-term setup into upcoming quarterly commentary. The call helped shift sentiment following a volatile period around the company’s major business combination and 2026 outlook framing. (investing.com)

Adding to the tape, Waters recently filed an 8-K that included financial statements tied to the former BD Biosciences & Diagnostic Solutions business it combined with, giving investors more granularity on the acquired operations and how the combined profile may look as integration progresses. That incremental disclosure can act as a catalyst when the market is still recalibrating expectations around the transaction. (investing.com)

With the stock reacting positively, the focus typically shifts to whether Waters can deliver against its 2026 framework and integration milestones while maintaining margins and synergies. Any additional updates around the combined company’s operating cadence—especially tied to quarterly results and forward commentary—are likely to remain the primary drivers of further upside or pullbacks. (ir.waters.com)